LXO Group at a glance
Founded in 2015, LXO Group is a leading specialty pharma buy and build platform with proven M&A and lifecycle management capabilities and the vision to become the digital leader in its field. The business is a proven growth platform with a strong M&A track record and a management that has a very clear organic and M&A based value creation strategy.
LXO Group has successfully integrated 20 acquisitions into the platform to date and its management have demonstrated strong lifecycle management skills to reinvigorate mature branded prescription drugs back to growth.
Value Creation Strategy
In addition to M&A, we have identified several organic growth initiatives which form the basis of our strategy. These include strengthening lifecycle management capabilities, implementing a digital go-to-market strategy, diversifying organic growth via in-licensing partnerships, scaling the organisation and optimising operations.
